|Study||Analytical method||Tissue||n||Total arsenic
|Abbreviations: IC-ICP-MS, ion chromatography inductively coupled plasma mass spectrometry; ICP-MS, inductively coupled plasma mass spectrometry; NA, not applicable; ND, not detected; NR, not reported.
aAll chickens in the study by Morrison (1969) were treated with roxarsone, and the FDA study (FDA 2011b) was an experimental study using roxarsone-treated and control chickens; the studies by Lasky et al. (2004) and Wallinga (2006) were not able to definitively determine which chicken samples had been treated with roxarsone. bAnnual mean concentrations from Food Safety and Inspection Service National Residue Program monitoring; the full range was not reported. cResults are for roxarsone-treated chickens with a 5-day withdrawal period.
|Lasky et al. 2004||NR||Liver||20,559||330–430b||NA|
|FDA 2011bc||ICP-MS and IC-ICP-MS||Liver||21||275–2,940||0.1–9.1|